Arena Pharma (ARNA) Announces Meeting with U.S. FDA Regarding Lorcaserin NDA

June 2, 2010 8:12 AM EDT Send to a Friend
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the US Food and Drug Administration (FDA) has notified the company of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login